Hygeia Healthcare Holdings Co., Limited

SEHK:6078 Stock Report

Market Cap: HK$9.0b

Hygeia Healthcare Holdings Valuation

Is 6078 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 6078 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6078 (HK$14.54) is trading below our estimate of fair value (HK$107.78)

Significantly Below Fair Value: 6078 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6078?

Key metric: As 6078 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 6078. This is calculated by dividing 6078's market cap by their current earnings.
What is 6078's PE Ratio?
PE Ratio11.6x
EarningsCN¥733.36m
Market CapCN¥8.49b

Price to Earnings Ratio vs Peers

How does 6078's PE Ratio compare to its peers?

The above table shows the PE ratio for 6078 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.5x
1515 China Resources Medical Holdings
17x32.0%HK$5.3b
3309 C-MER Medical Holdings
39xn/aHK$2.5b
2219 Chaoju Eye Care Holdings
8.5x14.1%HK$1.9b
1526 Rici Healthcare Holdings
5.4xn/aHK$1.9b
6078 Hygeia Healthcare Holdings
11.6x20.9%HK$9.0b

Price-To-Earnings vs Peers: 6078 is good value based on its Price-To-Earnings Ratio (11.6x) compared to the peer average (17.5x).

Price to Earnings Ratio vs Industry

How does 6078's PE Ratio compare vs other companies in the HK Healthcare Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
574 Pa Shun International Holdings
1.8xn/aUS$8.36m
No more companies available in this PE range
6078 11.6xIndustry Avg. 12.1xNo. of Companies10PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 6078 is good value based on its Price-To-Earnings Ratio (11.6x) compared to the Hong Kong Healthcare industry average (12.1x).

Price to Earnings Ratio vs Fair Ratio

What is 6078's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6078 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.6x
Fair PE Ratio18.3x

Price-To-Earnings vs Fair Ratio: 6078 is good value based on its Price-To-Earnings Ratio (11.6x) compared to the estimated Fair Price-To-Earnings Ratio (18.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 6078 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$14.54
HK$34.24
+135.5%
35.6%HK$67.70HK$18.11n/a14
Dec ’25HK$16.04
HK$34.89
+117.5%
33.7%HK$68.26HK$18.26n/a16
Nov ’25HK$17.80
HK$35.85
+101.4%
33.9%HK$69.59HK$18.62n/a16
Oct ’25HK$23.70
HK$35.85
+51.2%
33.9%HK$69.59HK$18.62n/a16
Sep ’25HK$19.58
HK$45.80
+133.9%
25.2%HK$69.99HK$27.73n/a16
Aug ’25HK$21.85
HK$48.39
+121.5%
17.3%HK$68.57HK$39.37n/a16
Jul ’25HK$28.15
HK$49.60
+76.2%
17.6%HK$68.38HK$39.26n/a16
Jun ’25HK$32.75
HK$49.82
+52.1%
17.6%HK$68.73HK$39.46n/a16
May ’25HK$32.45
HK$49.89
+53.8%
17.6%HK$68.85HK$39.53n/a16
Apr ’25HK$31.90
HK$51.75
+62.2%
18.2%HK$68.87HK$39.54n/a16
Mar ’25HK$30.20
HK$58.69
+94.3%
19.7%HK$77.40HK$39.39n/a16
Feb ’25HK$25.50
HK$61.66
+141.8%
18.1%HK$77.53HK$44.08n/a16
Jan ’25HK$35.30
HK$64.33
+82.2%
16.1%HK$78.07HK$44.38n/a15
Dec ’24HK$47.90
HK$66.97
+39.8%
8.0%HK$76.35HK$59.18HK$16.0415
Nov ’24HK$48.00
HK$66.97
+39.5%
8.0%HK$76.35HK$59.18HK$17.8015
Oct ’24HK$43.90
HK$68.09
+55.1%
9.5%HK$82.51HK$59.01HK$23.7015
Sep ’24HK$39.65
HK$70.40
+77.5%
8.7%HK$83.41HK$60.04HK$19.5815
Aug ’24HK$49.70
HK$71.73
+44.3%
7.1%HK$83.06HK$60.24HK$21.8515
Jul ’24HK$42.40
HK$69.43
+63.7%
9.0%HK$82.30HK$55.33HK$28.1515
Jun ’24HK$45.80
HK$69.30
+51.3%
9.6%HK$81.07HK$55.88HK$32.7515
May ’24HK$57.50
HK$70.65
+22.9%
9.4%HK$82.70HK$57.47HK$32.4515
Apr ’24HK$55.80
HK$70.71
+26.7%
9.3%HK$83.00HK$57.68HK$31.9015
Mar ’24HK$60.55
HK$66.49
+9.8%
11.8%HK$81.88HK$51.07HK$30.2013
Feb ’24HK$64.00
HK$62.75
-2.0%
9.4%HK$76.01HK$51.83HK$25.5012
Jan ’24HK$56.00
HK$58.46
+4.4%
7.2%HK$65.88HK$49.93HK$35.3012
Dec ’23HK$47.50
HK$56.21
+18.3%
7.9%HK$64.27HK$48.70HK$47.9011

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 22:10
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hygeia Healthcare Holdings Co., Limited is covered by 29 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sharon ShiBOCI Research Ltd.
Linda LuBOCI Research Ltd.
Ethan CuiBofA Global Research